Johnson & Johnson's consumer-health unit Kenvue made its debut on the New York Stock Exchange and jumped about 20% on Thursday. Thibaut Mongon, CEO of Kenvue, joined Cheddar News to discuss business growth goals and what lies ahead for its well-known pipeline of products, including Band-Aid, Neutrogena, Tylenol, among others.

Share:
More In Business
Elon Musk Defiantly Defends Himself in Tesla Tweet Trial
Elon Musk returned to federal court to defend himself against a class-action lawsuit that alleges he misled Tesla shareholders with a tweet about an aborted buyout that the billionaire defiantly insisted Tuesday he could have pulled off, had he wanted.
The Carbon Footprint Of Your 401k
David Brooks, financial advisor and CEO of Retire Smart, joined Cheddar News to discuss some of the mutual funds in your 401k whose portfolios include companies that can contribute to climate change. Investment vehicles to combat climate change or fight for social justice are available to choose from and are becoming popular inside the retirement workplace plans.
Load More